While alternative methods are promising, their effectiveness varies depending on the context. In vitro models can replicate human cell responses, but they lack the complexity of a full organism. In silico models require extensive data and validation to ensure accuracy. Despite these challenges, these methods can provide valuable information and complement traditional testing, often leading to more comprehensive risk assessments.
